DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
79.96
-0.21 (-0.26%)
At close: Aug 13, 2025, 4:00 PM
80.25
+0.29 (0.36%)
After-hours: Aug 13, 2025, 7:58 PM EDT
DexCom Employees
DexCom had 10,300 employees as of December 31, 2024. The number of employees increased by 700 or 7.29% compared to the previous year.
Employees
10,300
Change (1Y)
700
Growth (1Y)
7.29%
Revenue / Employee
$417,553
Profits / Employee
$55,485
Market Cap
31.36B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10,300 | 700 | 7.29% |
Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
Dec 31, 2022 | 7,600 | 600 | 8.57% |
Dec 31, 2021 | 7,000 | 600 | 9.38% |
Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
Dec 31, 2018 | 3,900 | 910 | 30.43% |
Dec 31, 2017 | 2,990 | 690 | 30.00% |
Dec 31, 2016 | 2,300 | 791 | 52.42% |
Dec 31, 2015 | 1,509 | 448 | 42.22% |
Dec 31, 2014 | 1,061 | 296 | 38.69% |
Dec 31, 2013 | 765 | 67 | 9.60% |
Dec 31, 2012 | 698 | 78 | 12.58% |
Dec 31, 2011 | 620 | 100 | 19.23% |
Dec 31, 2010 | 520 | 135 | 35.06% |
Dec 31, 2009 | 385 | 81 | 26.64% |
Dec 31, 2008 | 304 | 52 | 20.63% |
Dec 31, 2007 | 252 | -8 | -3.08% |
Dec 31, 2006 | 260 | 105 | 67.74% |
Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
DXCM News
- 13 days ago - 10 stocks favored to gain up to 30% in a sector that has missed this year's rally - Market Watch
- 14 days ago - DexCom, Inc. (DXCM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Dexcom beats estimates for quarterly results, names new CEO - Reuters
- 14 days ago - Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan - Business Wire
- 14 days ago - Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program - Business Wire
- 16 days ago - Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio - Business Wire
- 21 days ago - Tenovi Expands Access to Glucose Data for Remote Patient Monitoring and Cardiometabolic Programs Through Dexcom Integration - Business Wire
- 23 days ago - DexCom: Delivering Consistent Growth - Seeking Alpha